Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 338,126 | 413,738 | 750,269 | -221,760 | -104,468 |
| Depreciation Amortization | 52,686 | 41,204 | 36,940 | 31,082 | 19,687 |
| Income taxes - deferred | -53,276 | 62,195 | -340,156 | 0 | N/A |
| Accounts receivable | -34,927 | -245,472 | -588,398 | -21,118 | -17,518 |
| Other Working Capital | 15,578 | -190,669 | -672,799 | -18,913 | 140,026 |
| Other Operating Activity | 434,248 | 507,600 | 739,529 | 89,027 | 61,495 |
| Operating Cash Flow | $752,435 | $588,596 | $-74,615 | $-141,682 | $99,222 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -87,771 | -199,132 | -31,736 | 185,688 | -331,401 |
| PPE Investments | -333,006 | -156,323 | -49,337 | -57,217 | -99,689 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -5,941 |
| Investing Cash Flow | $-420,777 | $-355,455 | $-81,073 | $128,471 | $-437,031 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -1,095 | N/A | N/A | 391,107 | 47,544 |
| Debt Repayment | -515,191 | -2,024 | -2,203 | -119,167 | -1,028 |
| Common Stock Issued | 126,045 | 57,393 | 63,549 | 137,387 | 200,588 |
| Common Stock Repurchased | -267,584 | -195,087 | -163,300 | -25,078 | -3,798 |
| Other Financing Activity | 439,278 | 211,909 | 4,308 | 0 | 0 |
| Financing Cash Flow | $-218,547 | $72,191 | $-97,646 | $384,249 | $243,306 |
| Beginning Cash Position | 535,608 | 230,276 | 483,610 | 112,572 | 207,075 |
| End Cash Position | 648,719 | 535,608 | 230,276 | 483,610 | 112,572 |
| Net Cash Flow | $113,111 | $305,332 | $-253,334 | $371,038 | $-94,503 |
| Free Cash Flow | |||||
| Operating Cash Flow | 752,435 | 588,596 | -74,615 | -141,682 | 99,222 |
| Capital Expenditure | -333,006 | -156,323 | -49,337 | -57,217 | -99,689 |
| Free Cash Flow | 419,429 | 432,273 | -123,952 | -198,899 | -467 |